Systemic Sclerosis (Scleroderma):グローバル臨床試験レビューH1, 2013...市場調査レポートについてご紹介

【英文タイトル】Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Systemic Sclerosis (Scleroderma) 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Systemic Sclerosis (Scleroderma) 25
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Actelion Ltd 33
Clinical Trial Overview of Actelion Ltd 33
United Therapeutics Corporation 34
Clinical Trial Overview of United Therapeutics Corporation 34
ISDIN 35
Clinical Trial Overview of ISDIN 35
MediQuest Therapeutics, Inc. 36
Clinical Trial Overview of MediQuest Therapeutics, Inc. 36
MedImmune, LLC 37
Clinical Trial Overview of MedImmune, LLC 37
Celgene Corporation 38
Clinical Trial Overview of Celgene Corporation 38
Benesis Corporation 39
Clinical Trial Overview of Benesis Corporation 39
Actelion Pharmaceuticals Ltd 40
Clinical Trial Overview of Actelion Pharmaceuticals Ltd 40
Daval International Ltd. 41
Clinical Trial Overview of Daval International Ltd. 41
Amira Pharmaceuticals, Inc. 42
Clinical Trial Overview of Amira Pharmaceuticals, Inc. 42
Italfarmaco S.p.A. 43
Clinical Trial Overview of Italfarmaco S.p.A. 43
Apricus Biosciences, Inc. 44
Clinical Trial Overview of Apricus Biosciences, Inc. 44
Active Biotech AB 45
Clinical Trial Overview of Active Biotech AB 45
Pfizer Inc. 46
Clinical Trial Overview of Pfizer Inc. 46
Orion Oyj 47
Clinical Trial Overview of Orion Oyj 47
Sanofi 48
Clinical Trial Overview of Sanofi 48
Novartis AG 49
Clinical Trial Overview of Novartis AG 49
Hoffmann-La Roche Inc. 50
Clinical Trial Overview of Hoffmann-La Roche Inc. 50
Merck & Co., Inc. 51
Clinical Trial Overview of Merck & Co., Inc. 51
Gilead Sciences, Inc. 52
Clinical Trial Overview of Gilead Sciences, Inc. 52
Clinical Trial Overview of Top Institutes / Government 53
Assistance Publique – Hopitaux de Paris 53
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 53
Fred Hutchinson Cancer Research Center 54
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 54
National Institute of Arthritis and Musculoskeletal and Skin Diseases 55
Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 55
Duke University 56
Clinical Trial Overview of Duke University 56
Hospital for Special Surgery 57
Clinical Trial Overview of Hospital for Special Surgery 57
Georgetown University 58
Clinical Trial Overview of Georgetown University 58
University of Michigan 59
Clinical Trial Overview of University of Michigan 59
Stanford University 60
Clinical Trial Overview of Stanford University 60
National Center for Research Resources 61
Clinical Trial Overview of National Center for Research Resources 61
Boston University 62
Clinical Trial Overview of Boston University 62
Rouen University Hospital 63
Clinical Trial Overview of Rouen University Hospital 63
University of California, Los Angeles 64
Clinical Trial Overview of University of California, Los Angeles 64
Northwestern University 65
Clinical Trial Overview of Northwestern University 65
The Medical University of Graz 66
Clinical Trial Overview of The Medical University of Graz 66
The National Institute of Allergy and Infectious Diseases 67
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 67
Charite – Universitatsmedizin Berlin 68
Clinical Trial Overview of Charite – Universitatsmedizin Berlin 68
Sanjay Gandhi Postgraduate Institute of Medical Sciences 69
Clinical Trial Overview of Sanjay Gandhi Postgraduate Institute of Medical Sciences 69
Arthritis Research UK 70
Clinical Trial Overview of Arthritis Research UK 70
The University of Florence 71
Clinical Trial Overview of The University of Florence 71
Federal University of Sao Paulo 72
Clinical Trial Overview of Federal University of Sao Paulo 72
Five Key Clinical Profiles 73
Appendix 111
Abbreviations 111
Definitions 111
Research Methodology 112
Secondary Research 112
About GlobalData 113
Contact Us 113
Disclaimer 113
Source 114


【レポート販売概要】

■ タイトル:Systemic Sclerosis (Scleroderma):グローバル臨床試験レビューH1, 2013
■ 英文:Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2013
■ 発行日:2013年6月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403161314
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。